ARTICLE | Company News
Topokine, Allergan deal
May 2, 2016 7:00 AM UTC
Allergan acquired Topokine for $85 million up front. Topokine shareholders are also eligible for development and sales milestones tied to XAF5, a prostaglandin analog that induces a G protein-coupled...